FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 網易雲音樂股份有限公司 呈交日期： 2026年3月2日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 09899 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | 已發行股份（不包括 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 NETEASE CLOUD MUSIC INC. 網易雲音樂股份有限公司 （於開曼群島註冊成立的有限公司） （股份代號：9899） 根據2022年計劃授出現股獎勵 茲提述本公司的2022年計劃。董事會謹此宣佈，本公司於2026年3月2日向若干合 資格參與者（作為承授人）授出獎勵。授出詳情如下： 授出日期： 2026年3月2日 每股市價： 於授出日期的每股收市價為148.00港元。 承授人： 承授人及彼等授出的概要載列如下： 歸屬： 購買價 於歸屬時，每股獎勵股份的購買價為零。 歸屬期及時間表 每項授出自2026年3月1日起總歸屬期為三年，並應於三年 內平均歸屬。 其他主要限制： 表現目標 就各承授人而言，於各歸屬日期，歸屬的獎勵部分須視乎 承授人於歸屬日期前一年期間的業績表現是否達到指定門 檻而定。 1 承授人 授出獎勵數目 僱員參與者379名人士 649,127 關聯實體參與者5名人士 19,846 ...

本周观点 风险提示 后续政策不及预期风险；中美关系变化风险；内容上线及表现不及预期风险；宏观经济运行不及预期风险；AI 技 术迭代和应用不及预期风险；政策监管风险。 敬请参阅最后一页特别声明 1 咖啡茶饮：1）咖啡：高景气维持；行业具备β性红利，各品牌依旧积极开店，整体咖啡行业价格竞争趋缓；阿 拉比卡咖啡期货价格持续下跌，后续有望带来成本改善。2）茶饮：略有承压；短期平台 AI 流量大战，奶茶成为 引流品，数据依旧具备韧性；但有关"糖税"征收相关研究讨论引发市场担忧。 电商：持续承压。受国内消费环境影响，整体国内电商基本面表现平淡。 流媒体平台：音乐流媒体平台为内需驱动的优质互联网资产，高性价比悦己消费，规模效应驱动盈利杠杆释放。 网易云音乐 2025 年收入略微不及预期，关注 2026 年音乐订阅业务有望量价齐升。 虚拟资产&资产交易平台：地缘冲突风险加剧，币价持续承压。香港 2026-2027 年度财政预算案确认香港年内将 提交法案，建立虚拟资产交易商及托管服务提供者的发牌制度，监管范围将进一步扩展至场外交易等数字资产买 卖业务。 汽车服务：IAM中，多家主机系汽服连锁蛰伏后市场，车后连锁品牌持续加码开店 ...

Performance Summary - Xinyi Solar (00968.HK) reported a revenue of 20.861 billion yuan for 2025, a decrease of 4.8% year-on-year, with a net profit of 844.5 million yuan, down 16.2%, primarily due to a decline in average selling prices of solar glass products [2] - Zhongxin Innovation (03931.HK) expects a net profit of 2.025 billion to 2.193 billion yuan for 2025, an increase of approximately 140% to 160% compared to the previous year, driven by high growth in leading technology products across passenger, commercial, and energy storage sectors [2] - Rongchang Bio (09995.HK) anticipates a revenue of 3.251 billion yuan for 2025, an increase of 89.36% year-on-year, with a net profit of 709 million yuan, turning profitable due to increased sales of Tislelizumab and injection-use Vedolizumab [2] - Xinyi Energy (03868.HK) expects a revenue of 2.453 billion yuan for 2025, a slight increase of 0.53%, with a net profit of 1.011 billion yuan, up 27.79% [2] - Sihang Property (00083.HK) reported a revenue of 5.185 billion HKD for the six months ending December 31, 2025, an increase of 34.54%, while net profit decreased by 15.77% to 1.533 billion HKD [3] - Haohai Biological Technology (06826.HK) expects a revenue of approximately 2.473 billion yuan for 2025, a decrease of 8.33%, with a net profit of about 251 million yuan, down 40.3% [4] - Chunli Medical (01858.HK) anticipates a total revenue of approximately 1.044 billion yuan for 2025, a year-on-year increase of 29.52%, with a net profit of 272 million yuan, up 117.72% [5] - Baosheng International (03813.HK) issued a profit warning, expecting a net profit of approximately 211 million yuan for 2025, a decrease of about 57.1% [6] - Chip Intelligence Holdings (02166.HK) expects a net profit of approximately 140 million to 170 million HKD for 2025, an increase of about 40% to 70%, benefiting from the booming AI technology and increasing market demand [6] - Fengcai Technology (01304.HK) anticipates a total revenue of approximately 774 million yuan for 2025, a year-on-year increase of 28.91%, with a net profit of about 227 million yuan, up 1.92% [6] - Huayou Energy (01251.HK) issued a profit warning, expecting a loss of approximately 100 million to 150 million HKD for the 2025 fiscal year [7] - Zhoneng Group (00131.HK) reported a revenue of 272 million HKD for the six months ending December 31, 2025, an increase of 250.64%, with a net profit of 180 million HKD, turning profitable [8] - Fudan Zhangjiang (01349.HK) expects a revenue of approximately 686 million yuan for 2025, a decrease of 3.33%, with a net loss of approximately 157 million yuan, turning from profit to loss [9] Company News - Bay Area Development (00737.HK) reported that the total toll revenue for January from the Guangzhou-Shenzhen Expressway, Guangzhou-Zhuhai West Line Expressway, and the Shenzhen section of the Yangtze River Expressway was approximately 241 million, 105 million, and 75.169 million yuan, respectively, representing year-on-year growth of 15%, 17%, and 19% [10] - LeCang Logistics (02490.HK) plans to acquire two large container ships [10] - Innovent Biologics (01801) received approval for Jebatuzumab (Pimobendan) in China for the indication of relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma [11] Buyback Activities - Xiaomi Group-W (01810.HK) repurchased 2.8582 million shares for a total of approximately 99.9973 million HKD, with a repurchase price ranging from 34.92 to 35.04 HKD per share [12] - Geely Automobile (00175.HK) repurchased 3.673 million shares for approximately 59.4327 million HKD, with a repurchase price between 16.1 and 16.3 HKD [13] - Miniso Group (09896.HK) repurchased approximately 0.0526 million shares for about 1.8893 million HKD, with a repurchase price ranging from 35.64 to 36.34 HKD [14] - NetEase Cloud Music (09899.HK) repurchased approximately 0.09715 million shares for about 14.9959 million HKD, with an average repurchase price of 154.36 HKD [14]

格隆汇2月27日丨网易云音乐(09899.HK)公告，2月27日耗资1499.6万港元回购9.7万股。 ...

网易云音乐(09899)公布，2026年2月27日耗资约1499.59万港元回购9.715万股股份。 ...

智通财经APP讯，网易云音乐(09899)公布，2026年2月27日耗资约1499.59万港元回购9.715万股股份。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 網易雲音樂股份有限公司 呈交日期： 2026年2月27日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 第 1 頁 共 7 頁 v 1.3.0 FF305 | | | 第 2 頁 共 7 頁 v 1.3.0 FF305 確認 | 第一章節 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 09899 | 說明 | | | | | | | | | A. 已發行股份或庫存股份變動 | | | ...

Market Performance - The Hong Kong stock market showed a mixed performance with the Hang Seng Index rising by 0.95% to 26,630.54 points, the Hang Seng Tech Index increasing by 0.56% to 5,137.84 points, and the National Enterprises Index up by 0.51% to 8,859.49 points [1] - Major tech stocks exhibited varied movements, with Alibaba down by 0.07%, Tencent up by 1.17%, and Netease rising by 2.4% [1] Corporate Earnings - Baidu Group reported a total revenue of 32.7 billion yuan for Q4, a 5% quarter-on-quarter increase, with a NON-GAAP net profit of 3.9 billion yuan [2] - NIO's subsidiary, Shenji, signed a final agreement for a 2.257 billion yuan investment, focusing on smart driving chip business [2] Energy and Gaming Sector - Zhengli New Energy expects a net profit of 680 million to 820 million yuan for 2025, representing a year-on-year growth of approximately 647.25% to 801.10% [3] - Galaxy Entertainment anticipates a net income of 49.2 billion HKD for 2025, up 13% year-on-year, with a net profit increase of 22% [3] Financial and Real Estate Sector - Hong Kong Exchanges and Clearing reported total revenue of 29.161 billion HKD for 2025, a 30% year-on-year increase, with a net profit of 17.754 billion HKD, up 36% [4] - Sun Hung Kai Properties achieved revenue of 52.705 billion HKD for the six months ending December 31, 2025, a 31.98% increase year-on-year [4] Consumer and Healthcare Sector - Chow Tai Fook reported revenue of 10.485 billion HKD for the six months ending December 31, 2025, with a net profit increase of 15% [5] - Jiangnan Buyi's total revenue for the same period was approximately 3.376 billion HKD, up 7% year-on-year [5] - CanSino Biologics reported total revenue of 1.068 billion HKD for 2025, a 26.18% year-on-year increase [5] Other Corporate Earnings - BioAstute expects 2025 revenue of approximately 1.379 billion HKD, a 40.63% increase year-on-year [7] - Weitai Medical anticipates revenue of no less than 650 million yuan for 2025, an 88.1% year-on-year growth [7] Institutional Insights - UBS analysts believe that concerns regarding AI have created buying opportunities, increasing the weight of tech stocks in their portfolio [9] - Guoyuan International suggests that external environment improvements will likely lead to a bullish trend for Hong Kong stocks [10] - China Galaxy Securities highlights three investment directions: rising geopolitical risks, consumer sector recovery, and long-term tech investments [11]

点，跌幅随即扩大至 247 点，低见 23730 点，其后跌幅 一度收窄至仅 20 点，午后大盘走势偏软，尾盘沽压再 度扩大。截至收盘，恒指收报 23831 点，下跌 145 点或 0.61%；国指收报 9656 点，下跌 47 点或 0.49%，大市 成交进一步减至 827.99 亿。港股通录得净流入资金 4.84 亿，其中港股通(沪)净流入 2.83 亿，港股通(深)净 流入 2.01 亿。板块方面，本地地产、软件、5G 概念板 块跌幅靠前；黄金股逆市走强。 周四港股市场单边下挫，科网股全线走低，生物 科技股大跌。恒生指数收跌 1.44%，报 26381.02 点；恒生科技指数下挫 2.87%，报 5109.33 点； 恒生中国企业指数下跌 2.44%，报 8814.29 点。 市场成交额为 2592.77 亿港元，较前一交易日的 2367.65 亿港元有所增加。恒生指数成分股中， 中升控股重挫 10.8%，药明生物下挫 7.5%，新东 方-S 下跌 5.1%，长和上涨 4.5%，长江基建集团 上涨 4.5%，电能实业上涨 3.8%。恒生科技指数成 分股中，小鹏汽车-W 下跌 5.1%，华虹半导体下跌 4 ...